VIDEO: The SURPRISING Truth About IV Vitamin C and Cancer (Shocking Study)

The SURPRISING Truth About IV Vitamin C and Cancer

A new clinical study out of the University of Iowa is shaking up the oncology world—showing that high-dose intravenous vitamin C (HDIVC) doubled survival time in patients with metastatic pancreatic cancer. Dr. Mark Stengler, a naturopathic medical doctor with over 30 years of integrative cancer experience, breaks down this study and the growing science behind IV vitamin C therapy in this must-watch video.

🎥 Watch Now on YouTube

What the Study Showed:

• Patients receiving both chemotherapy and HDIVC lived 16 months on average, compared to 8.3 months with chemotherapy alone.
• HDIVC helped protect against the toxic side effects of chemo, including reduced white blood cell and platelet drop.
• Participants had blood vitamin C levels nearly 500x higher than those on chemo alone—without added side effects.

“This isn’t a cure—but for pancreatic cancer patients whose survival outlook is often grim, this kind of result is nothing short of remarkable.” —Dr. Mark Stengler

Why IV Vitamin C?

IV vitamin C offers several mechanisms of support:

• Generates hydrogen peroxide, toxic to cancer cells
• Boosts immune system defenses
• Supports cancer-fighting genes
• Provides anti-inflammatory benefits

Dr. Stengler co-authored Outside the Box Cancer Therapies with Dr. Paul Anderson, which explores HDIVC as part of a comprehensive cancer support protocol. This therapy, while still not widely adopted in conventional oncology, is increasingly used by integrative doctors around the world.

Looking for Integrative Cancer Support?

Contact the Stengler Center for Integrative Medicine in Encinitas, CA to schedule a personalized consultation.

‍